SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-004465
Filing Date
2020-01-22
Accepted
2020-01-22 16:20:11
Documents
1
Period of Report
2020-01-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4304
  Complete submission text file 0001209191-20-004465.txt   5769
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DECIPHERA PHARMACEUTICALS, LLC 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address
Flynn Daniel Lee (Reporting) CIK: 0001713712 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38219 | Film No.: 20539129